TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The Company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform.

Company Growth (employees)
Morrisville, US
Size (employees)
103 (est)-20%
TransEnterix was founded in 2006 and is headquartered in Morrisville, US

Key People at TransEnterix

Todd M. Pope

Todd M. Pope

President & CEO

TransEnterix Office Locations

TransEnterix has offices in Morrisville and Trezzano Rosa
Morrisville, US (HQ)
300 635 Davis Dr
Trezzano Rosa, IT
40 Via Firenze

TransEnterix Data and Metrics

TransEnterix Financial Metrics

TransEnterix's revenue was reported to be $1.5 m in FY, 2016

Revenue (FY, 2016)

1.5 m

Gross profit (FY, 2016)

450 k

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(120 m)

EBIT (FY, 2016)

(123.6 m)

Market capitalization (21-Jul-2017)

90 m

Cash (31-Dec-2016)

24.2 m
TransEnterix's current market capitalization is $90 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


1.4 m401 k1.5 m

Revenue growth, %


Cost of goods sold

4.8 m1.1 m1.1 m

Gross profit

(3.4 m)(694 k)450 k

Gross profit Margin, %


Sales and marketing expense

9.2 m

R&D expense

29.3 m

General and administrative expense

10.8 m

Operating expense total

22.2 m35.9 m46.4 m124.1 m


(25.6 m)(36.6 m)(46.4 m)(123.6 m)

EBIT margin, %


Interest expense

954 k1 m1.6 m1.9 m

Pre tax profit

(28.4 m)(37.7 m)(48 m)(125.5 m)

Income tax expense

2.8 m1 m1 m5.5 m

Net Income

(28.4 m)(37.7 m)(46.9 m)(120 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016


10 m34.8 m38.4 m24.2 m

Accounts Receivable

188 k133 k76 k621 k


3.9 m7.9 m

Current Assets

17.8 m35.7 m49.1 m38 m


1.9 m3.1 m4.4 m5.8 m


93.8 m93.8 m130.9 m68.7 m

Total Assets

116.7 m135.2 m248.6 m176.2 m

Accounts Payable

1.8 m1.8 m4.5 m4 m

Current Liabilities

7.1 m4.1 m31.1 m30.7 m

Total Liabilities

58.4 m

Additional Paid-in Capital

203 m257.6 m363.3 m426.6 m

Retained Earnings

(98.3 m)(135.9 m)(182.9 m)(302.8 m)

Total Equity

105 m121.8 m177.3 m117.9 m

Financial Leverage

1.1 x1.1 x1.4 x1.5 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4 m)(37.7 m)(46.9 m)(120 m)

Depreciation and Amortization

1.5 m1.3 m2.2 m7 m

Accounts Receivable

402 k55 k133 k(1 m)


731 k701 k(1.9 m)(6.6 m)

Accounts Payable

641 k(36 k)1.1 m(356 k)

Cash From Operating Activities

1.1 m(33.4 m)(38.8 m)(52.4 m)

Purchases of PP&E

(1.4 m)(2.2 m)(1.2 m)(1.4 m)

Cash From Investing Activities

(6.5 m)4 m(26.2 m)(1.4 m)

Cash From Financing Activities

53.9 m68.4 m49.9 m

Interest Paid

824 k904 k973 k1.3 m
Y, 2016

Financial Leverage

1.5 x

TransEnterix Operating Metrics

TransEnterix's Patent Applications was reported to be 40 in FY, 2016
FY, 2016

Patent Applications


Patents Issued


TransEnterix Market Value History

TransEnterix Online and Social Media Presence

TransEnterix Company Life and Culture

You may also be interested in